Senior housing deals worth $1.75 billion closed at Janus Living in one quarter.
Janus Living (JAN) reported Q3 2026 revenue of $268M, up 78% YoY, and Adjusted EBITDAre of $105M, up 101% YoY. The company closed $1.75B in senior housing deals, acquired life science buildings, and has $1.2B in liquidity. Net Debt to Adjusted EBITDAre was 4.7x. Guidance updated with a 50 bps increase in Same-Store Cash NOI midpoint.
How this was made
The 30-second read
Why it matters
Earnings beat and large deal flow suggest strong near‑term performance for senior‑housing REITs, while increased leverage warrants caution.
Market read
Primary earnings disclosure with sizable acquisition activity provides actionable insight for REIT investors.
What to watch
Potential impact of higher interest rates on REIT financing costs and occupancy risks in senior housing.
Background
The article reports Janus Living's Q3 2026 earnings and senior‑housing acquisition activity, plus Healthpeak's life‑science purchases and financing.
Ticker impact
Q3 2026 results show 78% revenue growth and $1.75B senior housing acquisitions closed, a primary earnings disclosure.
likely upside as market prices in robust growth and deal activity
Revenue and EBITDA surged double‑digits; senior housing acquisitions add scale, reducing risk of price decline.
Market effects
Highlights strength in senior‑housing REITs and life‑science real estate, supporting sector momentum.
Boosts US REIT market sentiment, especially senior‑housing and health‑care property segments.
Limited to US REIT investors; no direct global macro effect.
Counterpoint
Valuation may be stretched; rapid acquisition pace could pressure earnings if integration falters.
Key entities
- CompanyJanus Living
Senior‑housing REIT reporting Q3 results and $1.75B acquisitions.
- CompanyHealthpeak Properties
Health‑care REIT expanding life‑science portfolio with new acquisitions and a $500M loan.
